Hepatic Resection for Gastrointestinal Stromal Tumor Liver Metastases
Authors:
- Martin PalavecinoMartin Palavecino
- Eddie K. AbdallaEAEddie K. Abdalla
- 1 February 2009
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 23 (1) , 115-127
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GISTAnnals of Surgery, 2007
- Results of Tyrosine Kinase Inhibitor Therapy Followed by Surgical Resection for Metastatic Gastrointestinal Stromal TumorAnnals of Surgery, 2007
- Gastrointestinal stromal tumor (GIST)Annals of Oncology, 2006
- KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumoursEuropean Journal of Cancer, 2006
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal of Cancer, 2004
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Gastrointestinal Stromal Tumors and Leiomyosarcoma of the Abdomen and Retroperitoneum: A Clinical ComparisonAnnals of Surgical Oncology, 2001
- Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective DatabaseAnnals of Surgical Oncology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000